ADVFN - Advanced Financial Network.
HOME» NYSE » W » WPI Stock Price » WPI Stock News

Watson Share News

 Watson Pharmaceuticals, Inc. Stock Price
WPI Stock Price
 Watson Pharmaceuticals, Inc. Stock Chart
WPI Stock Chart
 Watson Pharmaceuticals, Inc. Stock News
WPI Stock News
 Watson Pharmaceuticals, Inc. Company Information
WPI Company Information
 Watson Pharmaceuticals, Inc. Stock Trades
WPI Stock Trades

Watson Pharmaceuticals Said Close To Buy Of Actavis For $7 Billion -Reuters

DOW JONES NEWSWIRES U.S.-based Watson Pharmaceuticals Inc. (WPI) is nearing a deal to buy Swiss generic drug maker Actavis Group for about $7 billion, Reuters reported Wednesday, citing three people familiar with the matter. Watson would pay between EUR5 billion and EUR5.5 billion in the transaction for Actavis, sources said. By virtue of a leveraged buyout in 2007, Deutsche Bank AG (DB) was left holding billions of euros in Actavis debt. Spokesmen for Watson, Actavis and Deutsche Bank declined comment to Reuters. Full story at: www.reuters.com/article/2012/03/21/us-actavis-watson-idUSBRE82K0ZK20120321 -Dow Jones Newswires; 212-416-2900

Stock News for Watson (WPI)
DateTimeHeadline
11/09/201215:37:51FDA Panel Splits on Merck Plan to Sell Bladder Drug Over-The-Counter
10/25/201214:46:46Mylan CEO Eyes Acquisitions Valued at More than $4 Billion
10/23/201209:01:03U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
10/15/201218:00:11FTC Clears Watson-Actavis Deal, With Conditions
10/12/201217:05:43Watson Pharmaceuticals Gains FDA Approval for Two Generics
09/27/201216:18:30Jumbo Deals Push Monthly Corporate Bond Volume to $115 Billion
08/15/201211:00:29Watson Pharma Sues FDA
07/13/201209:21:00Watson Pharmaceuticals: FDA Approves Generic of Teva's Plan B...
07/10/201204:08:08Correction to Shire's Generic Adderall XR Approval Story On June...
06/27/201210:28:00West Virginia Attorney General Sues Drug Distributors in Pill...
06/25/201217:49:29Watson Seeks FDA Approval Of Generic Pristiq
06/25/201209:21:18Shire Sinks On Generic Adderall XR Approval But Rebound Seen
05/29/201214:13:08Mylan Launches Generic Version of Blockbuster Lipitor
05/29/201209:15:58US HOT STOCK FUTURES: HOT STOCKS TO WATCH
04/30/201209:19:40US STOCK FUTURES: HOT STOCKS TO WATCH
04/27/201210:54:37Pharma M&A Surge Spurred By Necessity And Opportunity
04/26/201216:10:34US Stocks Climb As Housing Data Outweighs Weak Labor, Europe...
04/26/201211:27:59INTERVIEW: Actavis CEO To Leave Company After Watson Integration
04/25/201217:25:51Deutsche Bank Takes EUR257 Million Hit On Actavis-Watson Deal
04/24/201208:26:02Watson, Actavis To Unveil EUR4.5 Billion Merger Deal Wednesday

Watson Pharmaceuticals and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad